BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1601066)

  • 41. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antagonism of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane stimulus with a newly identified 5-HT2- versus 5-HT1C-selective antagonist.
    Ismaiel AM; De Los Angeles J; Teitler M; Ingher S; Glennon RA
    J Med Chem; 1993 Aug; 36(17):2519-25. PubMed ID: 8355253
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanisms involved in the hyperglycemic effect of the 5-HT1C/5-HT2 receptor agonist, DOI.
    Baudrie V; Chaouloff F
    Eur J Pharmacol; 1992 Mar; 213(1):41-6. PubMed ID: 1499656
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Behavioral and biochemical effects of amperozide and serotonin agents on nigrostriatal and mesolimbic dopamine systems.
    Chang PY; Chuang CH; Chen JC; Tung CS
    Chin J Physiol; 2008 Apr; 51(2):106-15. PubMed ID: 18666714
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
    Cohen ML; Schenck KW; Kurz KD
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
    [TBL] [Abstract][Full Text] [Related]  

  • 46. N(1)-substituted ergolines and tryptamines show species differences for the agonist-labeled 5-HT2 receptor.
    Johnson MP; Audia JE; Nissen JS; Nelson DL
    Eur J Pharmacol; 1993 Aug; 239(1-3):111-8. PubMed ID: 8223886
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurons in the hypothalamic paraventricular nucleus mediate the serotonergic stimulation of prolactin secretion via 5-HT1c/2 receptors.
    Rittenhouse PA; Levy AD; Li Q; Bethea CL; Van de Kar LD
    Endocrinology; 1993 Aug; 133(2):661-7. PubMed ID: 8344205
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interactions between 5-hydroxytryptamine (5-HT) and testosterone in the control of sexual and nonsexual behaviour in male and female rats.
    Gonzalez MI; Farabollini F; Albonetti E; Wilson CA
    Pharmacol Biochem Behav; 1994 Mar; 47(3):591-601. PubMed ID: 8208779
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulation of the 5-HT1C receptor-mediated behavior by 5-HT2, but not 5-HT1A, receptor activation.
    Chojnacka-Wójcik E
    Pol J Pharmacol Pharm; 1992; 44(5):427-36. PubMed ID: 1363616
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Facilitation of female rat lordosis behavior by hypothalamic infusion of 5-HT(2A/2C) receptor agonists.
    Wolf A; Caldarola-Pastuszka M; Uphouse L
    Brain Res; 1998 Jan; 779(1-2):84-95. PubMed ID: 9473601
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors.
    Kennett GA; Curzon G
    Br J Pharmacol; 1988 May; 94(1):137-47. PubMed ID: 3401632
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amperozide, a 5-HT2 antagonist, attenuates craving for cocaine by rats.
    McMillen BA; Jones EA; Hill LJ; Williams HL; Björk A; Myers RD
    Pharmacol Biochem Behav; 1993 Sep; 46(1):125-9. PubMed ID: 8255902
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
    Hoyer D; Engel G; Kalkman HO
    Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The 5-HT2 receptor agonist 1-(2,5-dimethoxy-4-iodophenyl)2-aminopropane increases brain tryptophan levels in the rat.
    Chaouloff F; Baudrie V; Layeillon C; Broqua P
    Eur J Pharmacol; 1992 Apr; 214(1):101-3. PubMed ID: 1533838
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serotonin-dependent collagenase induction in rat myometrial smooth muscle cells: mediation by the 5-HT2 receptor.
    Rydelek-Fitzgerald L; Wilcox BD; Teitler M; Jeffrey JJ
    Mol Cell Endocrinol; 1993 Feb; 91(1-2):67-74. PubMed ID: 8472855
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serotonin excitation of facial motoneurons: receptor subtype characterization.
    Rasmussen K; Aghajanian GK
    Synapse; 1990; 5(4):324-32. PubMed ID: 2360199
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An examination of the behavioural specificity of hypophagia induced by 5-HT1B, 5-HT1C and 5-HT2 receptor agonists using the post-prandial satiety sequence in rats.
    Kitchener SJ; Dourish CT
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):369-77. PubMed ID: 7862847
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 5-HT2 receptor agonists increase spontaneous sympathetic nerve discharge.
    McCall RB; Harris LT
    Eur J Pharmacol; 1988 Jun; 151(1):113-6. PubMed ID: 3416918
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Involvement of 5-HT1C-receptors in drug-induced penile erections in rats.
    Berendsen HH; Jenck F; Broekkamp CL
    Psychopharmacology (Berl); 1990; 101(1):57-61. PubMed ID: 2343074
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amperozide influences feeding independently of 5-HT2A receptor antagonism.
    Price IV; Gorzalka BB; White SJ; Arkinstall KH
    Neuropsychobiology; 1998; 37(3):155-9. PubMed ID: 9597673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.